Exploring benzodiazepine use among houston arrestees

Journal of Psychoactive Drugs

Volumn 34, Issue 4, 2002, Pages 393-399

  Yacoubian, George S ^a   Urbach, Blake J ^b   Larsen, Kristine L ^b   Johnson, Regina J ^c   Peters, Ronald J ^d  

^a McFarland Institute   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c PRAIRIE VIEW A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

ADAM; Arrestees; Benzodiazepines; Urinalysis

Indexed keywords

AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DEXTROPROPOXYPHENE; DIAMORPHINE; FLUNITRAZEPAM; METHAMPHETAMINE; OPIATE DERIVATIVE; PHENCYCLIDINE;

ACADEMIC ACHIEVEMENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CELL PROLIFERATION; CHI SQUARE DISTRIBUTION; CRIMINAL JUSTICE; DEMOGRAPHY; DRUG ABUSE; DRUG ABUSE PATTERN; DRUG MONITORING; FEMALE; HEALTH CARE POLICY; HUMAN; JUSTICE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRISON; STATISTICAL ANALYSIS; UNITED STATES; URINALYSIS;

EID: 0036823457     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2002.10399980     Document Type: Article

References (32)

1. Anglin, D.; Spears, K.L. & Hutson, H.R. 1997. Flunitrazepam and its involvement in date or acquaintance rape. Academy of Emergency Medicine 4: 323-26.
2. Avis, H. 1996. Drugs and Life. Madison, Wisconsin: Brown & Benchmark.
3. Budd, R.D. 1981. The use of diazepam and of cocaine in combination with other drugs by Los Angeles County probationers. American Journal of Drug and Alcohol Abuse 8 (2): 249-55.
4. Budd, R.D.; Walkin, E.; Jain, N.C. & Sneath, T.C. 1979. Frequency of the use of diazepam in individuals on probation and in methadone maintenance programs. American Journal of Drug and Alcohol Abuse 6 (4): 511-14.
5. Calhoun, S.R.; Wesson, D.R.; Galloway, G.P. & Smith, D.E. 1996. Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and South Texas. Journal of Psychoactive Drugs 28 (2): 183-89.
6. Darke, S.; Ross, J. & Cohen, J. 1994. The use ofbenzodiazepines among regular amphetamine users. Addiction 89 (12): 1683-90.
7. DuPont, R.L. 1988. Abuse of benzodiazepines: The problems and the solutions. American Journal of Drug and Alcohol Abuse 14: 1-69.
8. Elsohly, M.A. & Salamone, S.J. 1999. Prevalence of drugs used in cases of alleged sexual assault. Journal of Analytical Toxicology 23 (3): 141-6.
9. Forsyth, A.J.; Farquhar, D.; Gemmell, M.; Shewan, D. & Davies, J.B. 1993. The dual use of opioids and temazepam by drug injectors in Glasgow, Scotland. Drug andAlcohol Dependence 32 (3): 277-80.
10. Hammersley, R. & Pearl, S. 1997. Temazepam misuse, violence and disorder. Addiction Research 5 (3): 213-22.
11. Harrison, L.D. 1995. The validity of self-reported data on drug use. Journal of Drug Issues 25: 91-111.
12. Heishman, S. 1998. Pharmacodynamics. In: S.B. Karch (Ed.) Drug Abuse Handbook. Boca Raton, Florida: CRC Press
13. Kane, R. & Yacoubian, G. 1999. Patterns of drug escalation among Phi ladelphia arrestees: An assessment of the Gateway Theory. Journal of Drug Issues 29 (1): 107-20.
14. Katz, C.M. & Webb, V. 1996. Patterns ofdrug use among DUI arrestees. Journal of Crime and Justice 19 (2): 215-22.
15. Lcvinthal, C. 1996. Drugs, Behavior. and Modern Society. Boston, Massachusetts: Allyn & Bacon.
16. Makkai, T. & Marni, F. 1999. Drug Use Monitoring in Australia (DUMA): Preliminary results from the Southport site, 1999. Trends andIssues in Crime and Criminal Justice 142: 1-6.
17. National Institute of Justice. 2000. 1999 Arrestee Drug Abuse Monitoring (ADAM) Annual Report. Washington, D C.: U.S. Department of Justice.
18. Office of National Drug Control Policy (ONDCP). 2000. Pulse Check. Washington, D.C.: Office of National Drug Control Policy.
19. Ralston, G.E. & Taylor, J.A. 1993. Temazepam abuse. Addiction 88 (3): 423.
20. Rickert, V.I.; Wiemann, C.M. & Berenson, A.B. 1999. Prevalence, patterns, and correlates of voluntary flunitrazepam use. Pediatrics 103 (I): 1-5.
21. Rosenfeld, R. & Decker, S. 1993. Discrepant values, correlated measures: Cross-cities and longitudinal comparisons of self-reports and urine tests of cocaine use among arrestees. Journal of Criminal Justice 21:223-30.
22. Saum, C.A. & Inciardi, J.A. 1997. Rohypnol misuse in the United States. Substance Use & Misuse 32 (6): 723-31.
23. Slaughter, L. 2000. Involvement of drugs in sexual assault. Journal of Reproductive Medicine 45 (5): 425-30.
24. Wellisch, J.; Anglin, M.D. & Prendergast, ML. 1993. Numbers and characteristics of drug-using women in the criminal justice system: Implications for treatment. Journal of Drug Issues 23: 7-30.
25. Wish, E.D. 1990. U.S. drug policy in the 1990s: Insights from new data from arrestees. International Journal of the Addictions 25: 377-409.
26. Wish, E.D.; Hoffman, J.A. & Nemes, S. 1997. The validity of self-reports of drug use at treatment admission and at follow-up: Comparisons with urinalysis and hair assays. In: L. Harrison & A. Hughes (Eds.) The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates. Rockville, Maryland: National Institute of Drug Abuse.
27. Yacoubian, G. & Urbach, B.J. In press. Disproportional involvement in the use of crack and powder cocaine: Findings from the Arrestee Drug Abuse Monitoring (ADAM) Program. Alternate Routes.
28. Yacoubian, G. 2001. Assessing the temporal stability of drug-using classifications: An examination of Washington, D.C. arrestees between 1990 and 1997. Journal of Criminal Justice 29 (1): 21-30.
29. Yacoubian, G. 2000a. Reassessing the need for urinalysis as a validation technique. Journal of Drug Issues 30 (2): 323-34
30. Yacoubian, G. 2000b. Assessing ADAM's domain: Past, present, and future. Conlemporary Drug Problems 27: 121-35.
31. Yacoubian, G. 1999. A drug use typology for treatment intervention. Western Criminology Review I (2). Available at http://wcr.sonoma.edu/v I n2/yacoubian.html.
32. Yacoubian, G. & Kane, R. 1998. Identifying a drug use typology of Philadelphia arrestees: A cluster analysis. Journal of Drug Issues 28 (2): 559-74.